# L_2013303EN.01004001.xml

| 14.11.2013 | EN | Official Journal of the European Union | L 303/40 |
| --- | --- | --- | --- |

14.11.2013

EN

Official Journal of the European Union

L 303/40

---

COMMISSION IMPLEMENTING DECISION

of 12 November 2013

as regards a Union financial aid towards a coordinated control plan for antimicrobial resistance monitoring in zoonotic agents in 2014

(notified under document C(2013) 7289)

(2013/653/EU)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 882/2004 of the European Parliament and of the Council of 29 April 2004 on official controls performed to ensure the verification of compliance with feed and food law, animal health and animal welfare rules (1), and in particular Article 66 thereof,

Having regard to Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council of 25 October 2012 on the financial rules applicable to the general budget of the Union and repealing Council Regulation (EC, Euratom) No 1605/2002 (2) (the Financial Regulation), and in particular Article 84(2) thereof,

Whereas:

| (1) | Regulation (EC) No 882/2004 lays down, among others, procedures governing the financial support from the Union to conduct measures necessary to ensure the application of Regulation (EC) No 882/2004. |
| --- | --- |

(1)

Regulation (EC) No 882/2004 lays down, among others, procedures governing the financial support from the Union to conduct measures necessary to ensure the application of Regulation (EC) No 882/2004.

| (2) | Directive 2003/99/EC of the European Parliament and of the Council (3) provides that Member States shall ensure that monitoring provides comparable data on the occurrence of antimicrobial resistance (AMR) in zoonotic agents and, in so far as they present a threat to public health, other agents. |
| --- | --- |

(2)

Directive 2003/99/EC of the European Parliament and of the Council (3) provides that Member States shall ensure that monitoring provides comparable data on the occurrence of antimicrobial resistance (AMR) in zoonotic agents and, in so far as they present a threat to public health, other agents.

| (3) | Article 7(3) of this Directive provides that the Commission shall set out detailed rules for the implementation of monitoring of antimicrobial resistance. |
| --- | --- |

(3)

Article 7(3) of this Directive provides that the Commission shall set out detailed rules for the implementation of monitoring of antimicrobial resistance.

| (4) | Several scientific opinions published by the European Food Safety Authority and reports published by the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO) and the World Animal Health Organisation (OIE) call for a harmonised monitoring of antimicrobial resistance (AMR) in zoonotic and commensal bacteria, present in animals or food. The Commission therefore laid down detailed rules for harmonised monitoring and reporting of AMR in accordance with Article 7(3) of Directive 2003/99/EC to be carried out by the Member States in Commission Implementing Decision 2013/652/EU (4). |
| --- | --- |

(4)

Several scientific opinions published by the European Food Safety Authority and reports published by the World Health Organization (WHO), the Food and Agriculture Organization of the United Nations (FAO) and the World Animal Health Organisation (OIE) call for a harmonised monitoring of antimicrobial resistance (AMR) in zoonotic and commensal bacteria, present in animals or food. The Commission therefore laid down detailed rules for harmonised monitoring and reporting of AMR in accordance with Article 7(3) of Directive 2003/99/EC to be carried out by the Member States in Commission Implementing Decision 2013/652/EU (4).

| (5) | This harmonised monitoring must be performed in accordance with Article 3 of Regulation (EC) No 882/2004 ensuring that official controls are carried out regularly, on a risk basis and with appropriate frequency, so as to achieve the objectives of that Regulation taking account of identified risks associated with animals, feed or food, feed or food businesses, the use of feed or food or any process, material, substance, activity or operation that may influence feed or food safety, animal health or animal welfare. |
| --- | --- |

(5)

This harmonised monitoring must be performed in accordance with Article 3 of Regulation (EC) No 882/2004 ensuring that official controls are carried out regularly, on a risk basis and with appropriate frequency, so as to achieve the objectives of that Regulation taking account of identified risks associated with animals, feed or food, feed or food businesses, the use of feed or food or any process, material, substance, activity or operation that may influence feed or food safety, animal health or animal welfare.

| (6) | In order to facilitate smooth and fast application of this monitoring, the Union should financially support the Member States which carry out this monitoring at the most appropriate level as provided for in Article 66(1)(c) of Regulation (EC) No 882/2004. |
| --- | --- |

(6)

In order to facilitate smooth and fast application of this monitoring, the Union should financially support the Member States which carry out this monitoring at the most appropriate level as provided for in Article 66(1)(c) of Regulation (EC) No 882/2004.

| (7) | In accordance with Article 84 of the Financial Regulation and Article 94 of the Commission Delegated Regulation (EU) No 1268/2012 (5), the commitment of expenditure from the Union budget shall be preceded by a financing decision setting out the essential elements of the action involving expenditure and adopted by the institution or the authorities to which powers have been delegated by the institution. |
| --- | --- |

(7)

In accordance with Article 84 of the Financial Regulation and Article 94 of the Commission Delegated Regulation (EU) No 1268/2012 (5), the commitment of expenditure from the Union budget shall be preceded by a financing decision setting out the essential elements of the action involving expenditure and adopted by the institution or the authorities to which powers have been delegated by the institution.

| (8) | The measures eligible for Union financial support are defined within the current Implementing Decision. |
| --- | --- |

(8)

The measures eligible for Union financial support are defined within the current Implementing Decision.

| (9) | The financial contribution from the Union should be granted subject to the condition that the tests and analyses have been carried out in accordance with the present Implementing Decision and with Implementing Decision 2013/652/EU and that the competent authorities supply all the necessary information within the time limits laid down in the present Implementing Decision. |
| --- | --- |

(9)

The financial contribution from the Union should be granted subject to the condition that the tests and analyses have been carried out in accordance with the present Implementing Decision and with Implementing Decision 2013/652/EU and that the competent authorities supply all the necessary information within the time limits laid down in the present Implementing Decision.

| (10) | For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro and the conversion rate for expenditure in a currency other than the euro should be set, |
| --- | --- |

(10)

For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro and the conversion rate for expenditure in a currency other than the euro should be set,

HAS ADOPTED THIS DECISION:

Article 1

Subject matter

The Union shall contribute to the costs incurred by the Member States relating to the application of the harmonised antimicrobial resistance monitoring in accordance with Implementing Decision 2013/652/EU on samples of poultry collected between 1 January and 31 December 2014, with a total maximum amount of EUR 1 407 585 to be financed from line 17 04 07 01.

Article 2

Eligible costs

The Union financial contribution:

| (a) | shall be at a rate of 50 % of the costs incurred by each Member State to implement the monitoring referred to in Article 1 of Implementing Decision 2013/652/EU and performed by the competent authority; |
| --- | --- |

(a)

shall be at a rate of 50 % of the costs incurred by each Member State to implement the monitoring referred to in Article 1 of Implementing Decision 2013/652/EU and performed by the competent authority;

| (b) | shall not exceed the following:






  (i) | EUR 8 for staff costs per caecal sampling; |
| --- | --- | --- |

(b)

shall not exceed the following:

(i)

EUR 8 for staff costs per caecal sampling;

| (ii) | EUR 11 per E. coli isolation and identification; |
| --- | --- |

(ii)

EUR 11 per E. coli isolation and identification;

E. coli

| (iii) | EUR 21,5 per Campylobacter isolation and identification; |
| --- | --- |

(iii)

EUR 21,5 per Campylobacter isolation and identification;

Campylobacter

| (iv) | EUR 15 per antimicrobial susceptibility testing (AST) of each Salmonella or E. coli isolate; |
| --- | --- |

(iv)

EUR 15 per antimicrobial susceptibility testing (AST) of each Salmonella or E. coli isolate;

Salmonella

E. coli

| (v) | EUR 15 per AST of each Campylobacter isolate; |
| --- | --- |

(v)

EUR 15 per AST of each Campylobacter isolate;

Campylobacter

| (vi) | EUR 17,5 per characterisation and classification of Salmonella or E. coli isolates showing resistance to third-generation cephalosporins and meropenem; |
| --- | --- |

(vi)

EUR 17,5 per characterisation and classification of Salmonella or E. coli isolates showing resistance to third-generation cephalosporins and meropenem;

Salmonella

E. coli

| (vii) | EUR 22 per Salmonella serotyping; |
| --- | --- |

(vii)

EUR 22 per Salmonella serotyping;

Salmonella

| (viii) | the maximum amounts indicated in Annex I; |
| --- | --- |

(viii)

the maximum amounts indicated in Annex I;

| (c) | only the costs indicated in Annex II shall be eligible for contribution. |
| --- | --- |

(c)

only the costs indicated in Annex II shall be eligible for contribution.

Article 3

Eligibility rules

1.   The Union contribution is subject to the following conditions:

| (a) | by 31 May 2015, the Member States have provided to the European Food Safety Authority who was mandated for this task by the European Commission, with a technical report covering at least the information requested in Part B of the Annex to Implementing Decision 2013/652/EU; |
| --- | --- |

(a)

by 31 May 2015, the Member States have provided to the European Food Safety Authority who was mandated for this task by the European Commission, with a technical report covering at least the information requested in Part B of the Annex to Implementing Decision 2013/652/EU;

| (b) | by 31 May 2015, the Member States have provided the Commission, in electronic form, with a financial report according to the format laid out in Annex III to this Decision. In order to be eligible for funding, the expenditure incurred must have been paid before the submission of the claim. The supporting documents evidencing all the expenditure referred to in the financial report shall be sent to the Commission on request only. |
| --- | --- |

(b)

by 31 May 2015, the Member States have provided the Commission, in electronic form, with a financial report according to the format laid out in Annex III to this Decision. In order to be eligible for funding, the expenditure incurred must have been paid before the submission of the claim. The supporting documents evidencing all the expenditure referred to in the financial report shall be sent to the Commission on request only.

2.   The Commission may reduce the amount of the contributions referred to in Annex I in cases where the conditions referred to in paragraph 1 of this Article are not met, having regard to the nature and gravity of the non-compliance and to the potential financial loss for the Union.

Article 4

Conversion rate for expenditure

For reasons of administrative efficiency all expenditure submitted for a financial contribution by the Union should be expressed in euro. When a Member State’s expenditure is in a currency other than euro, the Member State shall convert it into euro by applying the most recent exchange rate set by the European Central Bank prior to the first day of the month in which the application is submitted by the Member State concerned.

Article 5

This Decision constitutes a financing decision in the meaning of Article 84 of Regulation (EU, Euratom) No 966/2012.

Article 6

This Decision is addressed to the Member States.

Done at Brussels, 12 November 2013.

For the Commission

Tonio BORG

Member of the Commission

---

(1)  
  OJ L 165, 30.4.2004, p. 1.

1

(2)  
  OJ L 298, 26.10.2012, p. 1.

2

(3)  Directive 2003/99/EC of the European Parliament and of the Council of 17 November 2003 on the monitoring of zoonoses and zoonotic agents (OJ L 325, 12.12.2003, p. 31).

3

(4)  Commission Implementing Decision 2013/652/EU of 12 November 2013 on the monitoring and reporting of antimicrobial resistance in zoonotic and commensal bacteria (see page 26 of this Official Journal).

4

(5)  Commission Delegated Regulation (EU) No 1268/2012 of 29 October 2012 on the rules of application of Regulation (EU, Euratom) No 966/2012 of the European Parliament and of the Council on the financial rules applicable to the general budget of the Union (OJ L 362, 31.12.2012, p. 1).

5

---

ANNEX I

Table 1

| Member States | Number of |
| --- | --- |
| Caecal samples | Isolation/Identification & AST | AST Salmonella | Serotyping Salmonella | Characterisation and classification of resistant isolates |
| Campylobacter | E. coli |
| BE | 850 | 170 | 170 | 550 | 550 | 150 |
| BG | 425 | 85 | 85 | 200 | 200 | 50 |
| CZ | 850 | 170 | 170 | 550 | 550 | 150 |
| DK | 850 | 170 | 170 | 250 | 250 | 100 |
| DE | 1 700 | 340 | 340 | 700 | 700 | 200 |
| EE | 425 | 85 | 85 | 100 | 100 | 50 |
| IE | 850 | 170 | 170 | 300 | 300 | 100 |
| EL | 850 | 170 | 170 | 450 | 450 | 100 |
| ES | 1 700 | 340 | 340 | 1 000 | 1 000 | 250 |
| FR | 1 700 | 340 | 340 | 800 | 800 | 250 |
| HR | 425 | 85 | 85 | 250 | 250 | 100 |
| IT | 1 700 | 340 | 340 | 800 | 800 | 250 |
| CY | 425 | 85 | 85 | 200 | 200 | 100 |
| LV | 425 | 85 | 85 | 100 | 100 | 50 |
| LT | 425 | 85 | 85 | 200 | 200 | 50 |
| LU | 425 | 85 | 85 | 100 | 100 | 50 |
| HU | 1 700 | 340 | 340 | 900 | 900 | 250 |
| MT | 425 | 85 | 85 | 100 | 100 | 50 |
| NL | 850 | 170 | 170 | 450 | 450 | 150 |
| AT | 1 700 | 340 | 340 | 550 | 550 | 200 |
| PL | 1 700 | 340 | 340 | 800 | 800 | 250 |
| PT | 1 700 | 340 | 340 | 500 | 500 | 200 |
| RO | 850 | 170 | 170 | 600 | 600 | 150 |
| SI | 425 | 85 | 85 | 200 | 200 | 50 |
| SK | 425 | 85 | 85 | 100 | 100 | 50 |
| FI | 850 | 170 | 170 | 50 | 50 | 50 |
| SE | 850 | 170 | 170 | 50 | 50 | 50 |
| UK | 1 700 | 340 | 340 | 800 | 800 | 250 |
| Total | 27 200 | 5 440 | 5 440 | 11 650 | 11 650 | 3 700 |

Member States

Number of

Caecal samples

Isolation/Identification & AST

AST Salmonella

Serotyping Salmonella

Characterisation and classification of resistant isolates

Campylobacter

E. coli

BE

850

170

170

550

550

150

BG

425

85

85

200

200

50

CZ

850

170

170

550

550

150

DK

850

170

170

250

250

100

DE

1 700

340

340

700

700

200

EE

425

85

85

100

100

50

IE

850

170

170

300

300

100

EL

850

170

170

450

450

100

ES

1 700

340

340

1 000

1 000

250

FR

1 700

340

340

800

800

250

HR

425

85

85

250

250

100

IT

1 700

340

340

800

800

250

CY

425

85

85

200

200

100

LV

425

85

85

100

100

50

LT

425

85

85

200

200

50

LU

425

85

85

100

100

50

HU

1 700

340

340

900

900

250

MT

425

85

85

100

100

50

NL

850

170

170

450

450

150

AT

1 700

340

340

550

550

200

PL

1 700

340

340

800

800

250

PT

1 700

340

340

500

500

200

RO

850

170

170

600

600

150

SI

425

85

85

200

200

50

SK

425

85

85

100

100

50

FI

850

170

170

50

50

50

SE

850

170

170

50

50

50

UK

1 700

340

340

800

800

250

Total

27 200

5 440

5 440

11 650

11 650

3 700

Table 2

| Member States | Maximum reimbursement (EUR) |
| --- | --- |
| Caecal sampling | E. coli Isolation & identification | Campylobacter Isolation & identification | Salmonella serotyping | AST | Characterisation & classification resistant isolates | Total | Overheads included (7 %) |
| Salmonella + E. coli | Campylobacter |
| BE | 6 800 | 2 200 | 14 800 | 14 700 | 10 800 | 2 600 | 2 700 | 54 600 | 58 422 |
| BG | 500 | 2 200 | 8 600 | 5 700 | 4 000 | 1 300 | 900 | 23 200 | 24 824 |
| CZ | 1 600 | 1 300 | 9 100 | 7 200 | 8 800 | 1 200 | 1 900 | 31 100 | 33 277 |
| DK | 6 800 | 2 200 | 18 300 | 9 300 | 6 300 | 2 600 | 1 800 | 47 300 | 50 611 |
| DE | 13 600 | 4 400 | 36 600 | 22 900 | 14 100 | 4 400 | 3 500 | 99 500 | 106 465 |
| EE | 400 | 1 000 | 3 300 | 4 100 | 2 200 | 1 100 | 200 | 12 300 | 13 161 |
| IE | 5 900 | 1 200 | 11 400 | 8 700 | 5 000 | 1 400 | 1 200 | 34 800 | 37 236 |
| EL | 2 000 | 2 200 | 14 900 | 7 700 | 8 500 | 2 600 | 1 300 | 39 200 | 41 944 |
| ES | 5 200 | 1 800 | 14 600 | 29 500 | 20 100 | 5 100 | 4 400 | 80 700 | 86 349 |
| FR | 13 600 | 4 400 | 36 600 | 25 100 | 17 100 | 4 100 | 4 400 | 105 300 | 112 671 |
| HR | 2 000 | 2 200 | 500 | 6 500 | 5 100 | 1 300 | 1 200 | 18 800 | 20 116 |
| IT | 13 600 | 4 400 | 25 000 | 16 500 | 12 200 | 3 700 | 2 700 | 78 100 | 83 567 |
| CY | 1 400 | 2 200 | 9 200 | 6 300 | 3 800 | 1 000 | 1 300 | 25 200 | 26 964 |
| LV | 700 | 900 | 3 400 | 3 900 | 1 600 | 800 | 500 | 11 800 | 12 626 |
| LT | 400 | 2 000 | 4 900 | 2 900 | 3 200 | 600 | 600 | 14 600 | 15 622 |
| LU | 3 400 | 2 200 | 9 200 | 4 100 | 2 800 | 1 300 | 900 | 23 900 | 25 573 |
| HU | 3 600 | 2 500 | 29 600 | 25 000 | 13 100 | 4 000 | 2 900 | 80 700 | 86 349 |
| MT | 1 300 | 500 | 5 500 | 3 500 | 2 000 | 700 | 900 | 14 400 | 15 408 |
| NL | 6 800 | 1 300 | 12 500 | 7 100 | 7 900 | 2 600 | 2 700 | 40 900 | 43 763 |
| AT | 13 600 | 4 400 | 36 600 | 17 000 | 13 400 | 5 100 | 3 500 | 93 600 | 100 152 |
| PL | 6 200 | 2 200 | 17 800 | 17 700 | 7 700 | 3 600 | 1 900 | 57 100 | 61 097 |
| PT | 4 400 | 3 900 | 36 600 | 18 500 | 5 600 | 2 100 | 1 700 | 72 800 | 77 896 |
| RO | 6 800 | 1 500 | 9 000 | 17 000 | 11 600 | 2 600 | 2 700 | 51 200 | 54 784 |
| SI | 3 400 | 1 900 | 9 200 | 5 200 | 2 700 | 1 300 | 900 | 24 600 | 26 322 |
| SK | 1 600 | 2 000 | 9 200 | 3 300 | 2 800 | 1 300 | 900 | 21 100 | 22 577 |
| FI | 6 800 | 1 900 | 8 300 | 0 | 3 300 | 2 300 | 900 | 23 500 | 25 145 |
| SE | 6 800 | 1 300 | 10 700 | 4 900 | 3 000 | 2 400 | 600 | 29 700 | 31 779 |
| UK | 13 600 | 3 600 | 36 600 | 25 100 | 17 100 | 5 100 | 4 400 | 105 500 | 112 885 |
| Total | 152 800 | 63 800 | 442 000 | 319 400 | 215 800 | 68 200 | 53 500 | 1 315 500 | 1 407 585 |

Member States

Maximum reimbursement (EUR)

Caecal sampling

E. coli Isolation & identification

Campylobacter Isolation & identification

Salmonella serotyping

AST

Characterisation & classification resistant isolates

Total

Overheads included (7 %)

Salmonella + E. coli

Campylobacter

BE

6 800

2 200

14 800

14 700

10 800

2 600

2 700

54 600

58 422

BG

500

2 200

8 600

5 700

4 000

1 300

900

23 200

24 824

CZ

1 600

1 300

9 100

7 200

8 800

1 200

1 900

31 100

33 277

DK

6 800

2 200

18 300

9 300

6 300

2 600

1 800

47 300

50 611

DE

13 600

4 400

36 600

22 900

14 100

4 400

3 500

99 500

106 465

EE

400

1 000

3 300

4 100

2 200

1 100

200

12 300

13 161

IE

5 900

1 200

11 400

8 700

5 000

1 400

1 200

34 800

37 236

EL

2 000

2 200

14 900

7 700

8 500

2 600

1 300

39 200

41 944

ES

5 200

1 800

14 600

29 500

20 100

5 100

4 400

80 700

86 349

FR

13 600

4 400

36 600

25 100

17 100

4 100

4 400

105 300

112 671

HR

2 000

2 200

500

6 500

5 100

1 300

1 200

18 800

20 116

IT

13 600

4 400

25 000

16 500

12 200

3 700

2 700

78 100

83 567

CY

1 400

2 200

9 200

6 300

3 800

1 000

1 300

25 200

26 964

LV

700

900

3 400

3 900

1 600

800

500

11 800

12 626

LT

400

2 000

4 900

2 900

3 200

600

600

14 600

15 622

LU

3 400

2 200

9 200

4 100

2 800

1 300

900

23 900

25 573

HU

3 600

2 500

29 600

25 000

13 100

4 000

2 900

80 700

86 349

MT

1 300

500

5 500

3 500

2 000

700

900

14 400

15 408

NL

6 800

1 300

12 500

7 100

7 900

2 600

2 700

40 900

43 763

AT

13 600

4 400

36 600

17 000

13 400

5 100

3 500

93 600

100 152

PL

6 200

2 200

17 800

17 700

7 700

3 600

1 900

57 100

61 097

PT

4 400

3 900

36 600

18 500

5 600

2 100

1 700

72 800

77 896

RO

6 800

1 500

9 000

17 000

11 600

2 600

2 700

51 200

54 784

SI

3 400

1 900

9 200

5 200

2 700

1 300

900

24 600

26 322

SK

1 600

2 000

9 200

3 300

2 800

1 300

900

21 100

22 577

FI

6 800

1 900

8 300

0

3 300

2 300

900

23 500

25 145

SE

6 800

1 300

10 700

4 900

3 000

2 400

600

29 700

31 779

UK

13 600

3 600

36 600

25 100

17 100

5 100

4 400

105 500

112 885

Total

152 800

63 800

442 000

319 400

215 800

68 200

53 500

1 315 500

1 407 585

---

ANNEX II

ELIGIBILITY RULES

1.   Laboratory costs

| — | Staff costs shall be limited to actual attributable labour costs (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained. |
| --- | --- |

—

Staff costs shall be limited to actual attributable labour costs (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.

| — | Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory designated by the competent authority. |
| --- | --- |

—

Reimbursement of consumables shall be based on actual costs incurred by Member States to perform the tests at the laboratory designated by the competent authority.

| — | Test kits, reagents and all other consumables shall only be reimbursed if used specifically in the performance of the following tests:






  (i) | E. coli isolation and identification; |
| --- | --- | --- |

—

Test kits, reagents and all other consumables shall only be reimbursed if used specifically in the performance of the following tests:

(i)

E. coli isolation and identification;

| (ii) | Campylobacter isolation and identification; |
| --- | --- |

(ii)

Campylobacter isolation and identification;

| (iii) | AST of Salmonella and E. coli isolates; |
| --- | --- |

(iii)

AST of Salmonella and E. coli isolates;

| (iv) | AST of Campylobacter isolates; |
| --- | --- |

(iv)

AST of Campylobacter isolates;

| (v) | Characterisation and classification of Salmonella and E. coli isolates showing resistance to third-generation cephalosporins and meropenem; |
| --- | --- |

(v)

Characterisation and classification of Salmonella and E. coli isolates showing resistance to third-generation cephalosporins and meropenem;

| (vi) | Salmonella serotyping. |
| --- | --- |

(vi)

Salmonella serotyping.

2.   Sampling costs

Costs for sampling shall be limited to staff costs of work within the slaughterhouse for the actual attributable labour (wages, social charges and retirement costs) accrued in implementation of Implementing Decision 2013/652/EU. To this end timesheets have to be maintained.

3.   Overheads

A flat rate contribution of 7 % calculated on the basis of all direct eligible costs may be claimed.

4.   The expenditure submitted by the Member States for a financial contribution by the Union shall be expressed in euro and shall exclude value added tax (VAT) and all other taxes.

---

ANNEX III

TEMPLATE FOR FINANCIAL REPORTS AS REFERRED TO IN ARTICLE 3(1)(B)

Reporting period: 2014

Member State: ...

Reference number of Commission Implementing Decision providing a financial contribution from the Union: 2013/653/EU

Laboratory costs (total effective eligible costs)

| E. coli isolation and identification |
| --- |
| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | | |
| Consumables (description) | Quantity | Unit cost (EUR) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | Total (EUR) | |
| Total nr of tests: | | Unit cost per analysis (EUR) | |
| Campylobacter isolation and identification |
| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | | |
| Consumables (description) | Quantity | Unit cost (EUR) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | Total (EUR) | |
| Total nr of tests: | | Unit cost per analysis (EUR) | |
| AST Salmonella and E. coli isolates |
| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | | |
| Consumables (description) | Quantity | Unit cost (EUR) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | Total (EUR) | |
| Total nr of tests: | | Unit cost per analysis (EUR) | |
| AST Campylobacter isolates |
| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | | |
| Consumables (description) | Quantity | Unit cost (EUR) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | Total (EUR) | |
| Total nr of tests: | | Unit cost per analysis (EUR) | |
| Characterisation and classification of resistant isolates |
| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | | |
| Consumables (description) | Quantity | Unit cost (EUR) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | Total (EUR) | |
| Total nr of tests: | | Unit cost per analysis (EUR) | |
| Salmonella serotyping |
| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | | |
| Consumables (description) | Quantity | Unit cost (EUR) | Total (EUR) |
| ... | | | |
| ... | | | |
| | | Total (EUR) | |
| Total nr of tests: | | Unit cost per analysis (EUR) | |

E. coli isolation and identification

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Consumables (description)

Quantity

Unit cost (EUR)

Total (EUR)

...

...

Total (EUR)

Total nr of tests:

Unit cost per analysis (EUR)

Campylobacter isolation and identification

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Consumables (description)

Quantity

Unit cost (EUR)

Total (EUR)

...

...

Total (EUR)

Total nr of tests:

Unit cost per analysis (EUR)

AST Salmonella and E. coli isolates

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Consumables (description)

Quantity

Unit cost (EUR)

Total (EUR)

...

...

Total (EUR)

Total nr of tests:

Unit cost per analysis (EUR)

AST Campylobacter isolates

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Consumables (description)

Quantity

Unit cost (EUR)

Total (EUR)

...

...

Total (EUR)

Total nr of tests:

Unit cost per analysis (EUR)

Characterisation and classification of resistant isolates

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Consumables (description)

Quantity

Unit cost (EUR)

Total (EUR)

...

...

Total (EUR)

Total nr of tests:

Unit cost per analysis (EUR)

Salmonella serotyping

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Consumables (description)

Quantity

Unit cost (EUR)

Total (EUR)

...

...

Total (EUR)

Total nr of tests:

Unit cost per analysis (EUR)

Sampling costs (total effective eligible costs)

| Staff category | Number of working hours | Rate (EUR per hour) | Total (EUR) |
| --- | --- | --- | --- |
| ... | | | |
| ... | | | |
| | | | |
| | | | |
| | | | |
| | | Total (EUR) | |
| Total nr of samples: | | Unit cost per sample (EUR) | |

Staff category

Number of working hours

Rate (EUR per hour)

Total (EUR)

...

...

Total (EUR)

Total nr of samples:

Unit cost per sample (EUR)

| Total expenditure for the coordinated control programme (real costs, VAT excluded) (EUR): | ... |
| --- | --- |

Total expenditure for the coordinated control programme (real costs, VAT excluded) (EUR):

...

Declaration by the beneficiary

We certify that:

| — | the expenditure listed above was incurred in the performance of tasks described in Implementing Decision 2013/652/EU and directly related to the implementation of the coordinated control plan for which financial support was granted according to Implementing Decision 2013/653/EU; |
| --- | --- |

—

the expenditure listed above was incurred in the performance of tasks described in Implementing Decision 2013/652/EU and directly related to the implementation of the coordinated control plan for which financial support was granted according to Implementing Decision 2013/653/EU;

| — | the expenditure was actually incurred, paid by the submission date of the current claim, accurately accounted for and eligible under the provisions of Implementing Decision 2013/653/EU; |
| --- | --- |

—

the expenditure was actually incurred, paid by the submission date of the current claim, accurately accounted for and eligible under the provisions of Implementing Decision 2013/653/EU;

| — | all supporting documents supporting for the costs are available for audit purposes; |
| --- | --- |

—

all supporting documents supporting for the costs are available for audit purposes;

| — | no other contribution from the Union was requested for this coordinated control plan. |
| --- | --- |

—

no other contribution from the Union was requested for this coordinated control plan.

Date: ...

Person responsible: ...

Signature: ...

---